AstraZeneca, Rigel Sign Potentially $100M Asthma Drug Deal – Genetic Engineering News

AstraZeneca, Rigel Sign Potentially $100M Asthma Drug Deal
Genetic Engineering News
Drug firm will start first-in-man studies and carry out clinical development program for R256.

and more »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.